Smith B B
College of Veterinary Medicine, Oregon State University, Corvallis, USA.
Vet Hum Toxicol. 1998;40 Suppl 1:29-34.
The North American llama and alpaca industries will probably continue to expand at a rate of 20-25% per year for at least the next one to two decades. As a result, while the total population will always be small relative to the cattle and swine industries, the total numbers of alpacas and llamas will be substantial. Accordingly, it is appropriate and timely to begin the process of getting drugs approved for usage in these species. Four drugs that warrant consideration for NRSP-7 evaluation and approval are: Ivermectin for the prevention of P. tenuis infections. Chlorsulon for the treatment of Fasciola hepatica infections. Ceftiofur sodium for the treatment of various bacterial infections. Omeprazole for the management and prevention of third compartment ulcers.
北美骆驼和羊驼养殖业在未来至少一到二十年里可能会继续以每年20% - 25%的速度扩张。因此，尽管与牛和猪养殖业相比，其总存栏量一直较少，但羊驼和骆驼的总数仍将相当可观。相应地，开始进行药物在这些物种中使用的审批过程是恰当且及时的。四种值得考虑由NRSP - 7评估和批准的药物是：用于预防捻转血矛线虫感染的伊维菌素；用于治疗肝片吸虫感染的氯舒隆；用于治疗各种细菌感染的头孢噻呋钠；用于管理和预防第三胃溃疡的奥美拉唑。
